Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1983-05-18
1989-03-07
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514843, A61K 3156
Patent
active
048107000
ABSTRACT:
An estrogen sulfotransferase inhibitor composition comprises a compound of the formula ##STR1## wherein R.sub.1 is F, Br, NO.sub.2, or H; R.sub.2 is F, Br, NO.sub.2, NH.sub.2, or H; R is H or alkyl of 1-4 carbon atoms; R.sub.3 is O or H.sub.2 ; and R.sub.4 is H.sub.2, O, or .alpha.-H, .beta.-OH; R.sub.5 is H.sub.2, .alpha.-H and .beta.-OH or B-H and .alpha.-OH in admixture with a pharmaceutically acceptable carrier with the proviso that R.sub.1, R.sub.2 and R.sub.3 cannot all be hydrogen and one of R.sub.1 and R.sub.2 is F.
REFERENCES:
Utne et al., "Journal of Organic Chemistry", Jun. (1968), pp. 2469-2473.
Lipovsky Joseph A.
Schenkman Leonard
Wayne State University
Williams, Jr. Sidney B.
LandOfFree
Compositions inhibiting estrogen sulfotransferase activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions inhibiting estrogen sulfotransferase activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions inhibiting estrogen sulfotransferase activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1668955